Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/108867) titled 'Skin Sensitization Activity of Boreum UVBeat Hydrating & Barrier Protecting Sunscreen SPF 50 PA++++ (SF109)' on April 21.
Study Type: Interventional
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Boreum Private Limited
Intervention:
Intervention1: Finn Chamber: Each Patch contain 0.04ml/(40 microgram) of test sample,1. UVBeat Hydrating & Barrier Protecting Sunscreen SPF 50 PA++++ (SF109), Administration: Topical Frequency: every second day- as per ISO 10993 Pa...